Autolus Therapeutics (AUTL) Other Operating Expenses (2017 - 2025)
Historic Other Operating Expenses for Autolus Therapeutics (AUTL) over the last 8 years, with Q1 2025 value amounting to -$3000.0.
- Autolus Therapeutics' Other Operating Expenses changed N/A to -$3000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was -$3000.0, marking a year-over-year increase of 9865.47%. This contributed to the annual value of -$223000.0 for FY2024, which is 9411.76% up from last year.
- Autolus Therapeutics' Other Operating Expenses amounted to -$3000.0 in Q1 2025.
- In the past 5 years, Autolus Therapeutics' Other Operating Expenses registered a high of $3.8 million during Q1 2023, and its lowest value of -$515000.0 during Q4 2022.
- Moreover, its 5-year median value for Other Operating Expenses was -$4000.0 (2021), whereas its average is $433142.9.
- Over the last 5 years, Autolus Therapeutics' Other Operating Expenses had its largest YoY gain of 1277500.0% in 2022, and its largest YoY loss of 1277500.0% in 2022.
- Quarter analysis of 5 years shows Autolus Therapeutics' Other Operating Expenses stood at -$4000.0 in 2021, then tumbled by 12775.0% to -$515000.0 in 2022, then skyrocketed by 95.53% to -$23000.0 in 2023, then tumbled by 869.57% to -$223000.0 in 2024, then surged by 98.65% to -$3000.0 in 2025.
- Its Other Operating Expenses was -$3000.0 in Q1 2025, compared to -$223000.0 in Q3 2024 and -$23000.0 in Q2 2023.